The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats

Neurotoxicology and Teratology

Volumn 26, Issue 4, 2004, Pages 571-577

  Darvesh, Altaf S ^a   Gudelsky, Gary A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Glycogenolysis; Hyperthermia; MDMA; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; GLYCOGENOLYSIS; HYPERTHERMIA; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; BRAIN; BRAIN CHEMISTRY; FEVER; GLYCOGEN STORAGE DISEASE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 2942623836     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.03.008     Document Type: Article

References (58)

1. Aguirre N., Barrionuevo M., Lasheras B., Del Rio J. The role of dopaminergic systems in the perinatal sensitivity to 3, 4- methylenedioxymethamphetamine-induced neurotoxicity in rats. J. Pharmacol. Exp. Ther. 286:1998;1159-1165
2. Battaglia G., Yeh S.Y., O'Hearn E., Molliver M.E., Kuhar M.J., DeSouza E.B. 3, 4-methylenedioxymethamphetamine and 3, 4-methylenedioxyamphetamine destroy serotonergic terminals in rat brain: quantification of neurodegeneration by measurement of [3H] paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 242:1987;911-916
3. Bowyer J.F., Tank A.W., Newport G.D., Slikker W. Jr., Ali F., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260:1992;817-824
4. Bowyer J.F., Gough B., Slikker W. Jr., Lipe G.W., Newport G.D., Holsen R.R. Effects of a cold environment on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44:1993;87-98
5. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holsen R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1994;1571-1580
6. Broening H.W., Bacon L., Slikker W. Jr. Age modulates the long term but not the acute effects of the serotonergic neurotoxicant 3, 4- methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 271:1994;285-293
7. Broening H.W., Bowyer J.F., Slikker W. Jr. Age-dependent sensitivity of long-term effects of the serotonergic neurotoxicant 3, 4- methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther. 275:1995;325-333
8. Burrows K.B., Gudelsky G.A., Yamamoto B.K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3, 4- methylenedioxymethamphetamine administration. Eur. J. Pharmacol. 398:2000;11-18
9. Chan P., DiMonte D.A., Luo J.J., DeLanney L.E., Irwin I., Langston J.W. Rapid ATP loss by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62:1994;2484-2487
10. Colado M.I., Green A.R. The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents "ecstasy"-induced neurodegeneration of 5-hydroxytryptamine neurons. Eur. J. Pharmacol. 280:1995;343-346
11. Colado M.I., O'Shea E., Granados R., Murray T.K., Green A.R. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (ecstasy) and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol. 121:1997;889-900
12. 2 receptors induces glycogenolysis in the rat brain. Eur. J. Pharmacol. 464:2003;135-140
13. Darvesh A.S., Shankaran M., Gudelsky G.A. 3, 4- methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J. Pharmacol. Exp. Ther. 300:2002;138-144
14. Farfel G.M., Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity: 1. Experiments using 3, 4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Ther. 272:1995;860-867
15. Farfel G.M., Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity: 2. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextrometahorphan. J. Pharmacol. Exp. Ther. 272:1995;868-875
16. Gordon C.J., Watkinson W.P., O'Callaghan J.P., Miller D.B. Effects of 3, 4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol. Biochem. Behav. 38:1991;339-344
17. Green A.R., Cross A.J., Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine. Psychopharmacology. 119:1995;247-260
18. Gudelsky G.A. Effect of ascorbate and cysteine on the 3, 4-methylenedioxymethamphetamine-induced depletion of brain serotonin. J. Neural Transm. 103:1996;1397-1404
19. Heuther G., Zhou D., Rüther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. J. Neural Transm. 104:1997;771-794
20. Huang N.K., Wan F.J., Tseng C.J., Tung C.S. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats. NeuroReport. 8:1997;1883-1885
21. Hutchins D.A., Rogers K.J. Physiological and drug-induced changes in the glycogen content of mouse brain. Br. J. Pharmacol. 39:1970;9-25
22. LaManna J.C., Sylvia A.L., Martel D., Rosenthal M. Fluometric monitoring of the effects of adrenergic agents on oxidative metabolism. Neuropharmacology. 15:1976;17-24
23. Lucot J.B., Horwitz J., Seiden L.S. The effects of p-chloroamphetamine administration on locomotor activity and serotonin in neonatal rats and adult rats. J. Pharmacol. Exp. Ther. 217:1981;738-744
24. Magistretti P.J., Sorg O., Martin J. Regulation of glycogen metabolism in astrocytes: physiological, pharmacological, and pathological aspects. Murphy S. Astrocytes, Pharmacology and Function. 1993;243-265 Academic Press, San Diego
25. Malberg J.E., Seiden L.S. Small changes in ambient temperature cause large changes in 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 18(13):1998;5086-5094
26. Malberg J.E., Sabol K.E., Seiden L.S. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J. Pharmacol. Exp. Ther. 278:1996;258-267
27. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;752-760
28. Miller R.T., Lau S.S., Monks T.J. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-α-methyldopamine on brain dopamine, serotonin and norepinephrine concentrations in male Sprague-Dawley rats. Chem. Res. Toxicol. 9:1996;457-465
29. Miller R.T., Lau S.S., Monks T.J. 2, 5-bis-(Glutathion-S-yl)-α- methyldopamine, a putative metabolite of (±)-3, 4- methylenedioxyamphetamine, decreases brain serotonin concentrations. Eur. J. Pharmacol. 323:1997;173-180
30. Nahorski S.R., Rogers K.J. An enzymic fluometric micromethod for determination of glycogen. Anal. Biochem. 49:1972;492-497
31. Nahorski S.R., Rogers K.J. In vivo effects of amphetamine on metabolites and metabolic rate in rat brain. J. Neurochem. 21:1973;679-686
32. Nahorski S.R., Rogers K.J. The role of catecholamines in the action of amphetamine and L-dopa on cerebral energy metabolism. Neuropharmacology. 14:1975;283-290
33. Nash J.F. Jr., Meltzer H.Y., Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after administration of 3, 4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 245:1988;873-879
34. Nash J.F., Roth B.L., Brodkin J.D., Nicols D.E., Gudelsky G.A. Effect of the R (-) and S (+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci. Lett. 177:1994;111-115
35. Nixdorf W.L., Burrows K.B., Gudelsky G.A., Yamamoto B.K. Enhancement of 3, 4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. J. Neurochem. 77:2001;647-654
36. Nomura Y., Naitoh F., Segawa T. Regional changes in monoamine content and uptake of the rat brain during postnatal development. Brain Res. 101:1976;305-315
37. Nowak T.S. Effects of amphetamine on protein synthesis and energy metabolism in mouse brain: role of drug-induced hyperthermia. J. Neurochem. 50:1988;285-294
38. O'Hearn E., Battaglia G., DeSouza E.B., Kuhar M.J., Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) causes selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8:1988;2788-2803
39. Palvimaki E.P., Roth B.L., Majasuo H., Laakso A., Kuoppamaki M., Syvalathi E., Hietala J. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology. 126:1996;234-240
40. Poblete J.C., Azmitia E.C. Activation of glycogen phosphorylase by serotonin and 3, 4-methylenedioxymethamphetamine in astroglial rich primary cultures: involvement of the 5-HT2A receptor. Brain Res. 680:1995;9-15
41. Pu C., Vorhees C.V. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocytic reaction in the rat striatum. Dev. Brain Res. 72:1993;325-328
42. Quach T.T., Rose C., Duchemin A.M., Schwartz J.C. Glycogenolysis induced by serotonin in brain: identification of a new class of receptor. Nature (Lond.). 298:1982;373-375
43. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240:1987;1-7
44. Schmidt C.J., Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol. 36:1987;4095-5102
45. 2 receptors. Brain Res. 529:1990;85-90
46. Shankaran M., Yamamoto B.K., Gudelsky G.A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3, 4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385:1999;103-110
47. Shankaran M., Yamamoto B.K., Gudelsky G.A. Mazindol attenuates the 3, 4-methylenedioxymethamphetamine-induced formation of hydroxy radicals and long term depletion of serotonin in the striatum. J. Neurochem. 72:1999;2516-2521
48. Shankaran M., Yamamoto B.K., Gudelsky G.A. Ascorbic acid prevents 3, 4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse. 40:2001;55-64
49. Stephens S.E., Whittingham T.S., Douglas A.J., Lust W.D., Yamamoto B.K. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in the striatum. J. Neurochem. 71:1998;613-621
50. St. Omer V.E.V., Ali S.F., Holson R.R., Frith C.H., Slikker W. Jr. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. Neurobehav. Toxicol. Teratol. 13:1991;13-20
51. Stone D.M., Stahl D., Hanson G.R., Gibb J.W. The effects of 3, 4-methylenedioxymethamphetamine on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128:1986;41-49
52. Swaiman K.F. Energy and electrolyte changes during maturation. Himwich W.A. Developmental Biology. 1970;311-330 Charles C. Thomas, Springfield, IL
53. Sylvia A.L., LaManna J.C., Rosenthal M., Jobsis F.F. Metabolite studies of methamphetamine effects based upon mitochondrial respiratory state in rat brain. J. Pharmacol. Exp. Ther. 201:1977;117-125
54. Tsacopoulos M., Magisretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885
55. Vaughn J.E. Glycogen in the synaptic boutons of developing rat spinal cord. Anat. Rec. 169:1971;446
56. Vaughn J.E., Grieshaber J.A. An electron microscopic investigation of glycogen and mitochondria in developing and adult rat spinal motor neuropil. J. Neurocytol. 1:1972;397-412
57. Wan F.J., Lin H.C., Kang B.H., Tseng C.J., Tung C.S. D-Amphetamine- induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res. Bull. 50(3):1999;167-171
58. Waxman D.J., Dannan G.A., Guengerich F.P. Regulation of rat hepatic P-450: age-dependent expression hormonal imprinting and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry. 24:1985;4409-4417